Inventor · disambiguated record
Amy Rachel Rappaport
Also filed as: RAPPAPORT AMY RACHEL
4 granted patents·17 pending applications·5 citations·filing 2018–2025
68Inventor score
Top patents by PatentIndex Score
21 records- 0189US12109257B2Alphavirus neoantigen vectorsGRITSTONE BIO INC·Filed 2022·Granted Oct 8, 2024·1 cites·20 claims
- 0288US11771747B2Multiepitope vaccine cassettesGRITSTONE BIO INC·Filed 2022·Granted Oct 3, 2023·2 cites·23 claims
- 0388US11510973B2Alphavirus antigen vectorsGRITSTONE BIO INC·Filed 2022·Granted Nov 29, 2022·1 cites·57 claims
- 0483US2025249084A1Alphavirus antigen vectorsGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0580US11504421B2Alphavirus neoantigen vectorsGRITSTONE BIO INC·Filed 2018·Granted Nov 22, 2022·1 cites·30 claims
- 0669US2025025544A1Immune checkpoint inhibitor co-expression vectorsGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0767US2024285739A1Multiepitope vaccine cassettesGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 0863US2024238412A1Pancoronavirus vaccinesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0960US2024238397A1Kras-neoantigen therapiesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1059US2025121052A1Sars-cov-2 vaccinesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1159US2023310563A1Antigen-encoding cassettesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1258US2023020089A1Shared neoantigen vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1358US2023303614A1Capping compounds, compositions and methods of use thereofGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1457US2023047979A1Durable vaccinationGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1557US2024050550A1Infectious disease antigens and vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1657US2023330215A1Sars-cov-2 vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1756US2021213122A1Immune checkpoint inhibitor co-expression vectorsGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 1853US2024093235A1Homologous adenoviral vaccinationGRITSTONE BIO INC·Filed 2021·Application pending·0 cites
- 1951US2022125919A1Alphavirus neoantigen vectors and interferon inhibitorsGRITSTONE BIO INC·Filed 2019·Application pending·0 cites
- 2044US2025276049A1Egfr vaccine cassettesGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 2142US2025269002A1Cta vaccine cassettesGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →